Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
tellic is a private U.S. life sciences software company that provides AI- and machine learning-based biomedical language processing, knowledge graph, and data curation products for pharmaceutical and biotechnology customers. The company focuses on helping research and commercial teams extract relationships and evidence from biomedical text and other data sources to support target prioritization, hypothesis generation, clinical trial design, and drug repurposing workflows. Its offerings include tellic graph, drug360 graph, and the COVID-19-focused graph.C19, all positioned as enterprise-scale tools for knowledge discovery in pharma. tellic appears to operate as a commercial software/platform business rather than a therapeutics developer, so it does not have a conventional drug pipeline. The company emphasizes large language models, natural language processing, and ontology-linked knowledge graphs tailored to pharma organizations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on tellic.